Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00284960 · ClinicalTrials.gov registry record
The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
A clinical trial of Insulin Resistance and Metabolic Syndrome, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT00284960 is a study of Insulin Resistance and Metabolic Syndrome that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 30 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00284960, a study of Insulin Resistance and Metabolic Syndrome, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Determine if men with erectile dysfunction (ED) are more likely to have insulin resistance compared to healthy controls.
Conditions Studied
Study Locations (1)
Pennsylvania
- Hershey Med Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00284960
The ClinicalTrials.gov registry entry for NCT00284960 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (88% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 0 interventions.
NCT00284960 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00284960 about?
NCT00284960 is a clinical study titled "The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction". Determine if men with erectile dysfunction (ED) are more likely to have insulin resistance compared to healthy controls.
What is the current status of trial NCT00284960?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2005-06. Estimated completion is 2007-03.
What conditions does trial NCT00284960 study?
This clinical trial studies the following conditions: Insulin Resistance, Metabolic Syndrome, Erectile Dysfunction.
Who is sponsoring clinical trial NCT00284960?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00284960 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.